Ringoes, NJ, United States of America

Eileen Marie Kajkowski


Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 1997-2006

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Eileen Marie Kajkowski: Innovator in Biotechnology

Introduction

Eileen Marie Kajkowski is a prominent inventor based in Ringoes, New Jersey. She has made significant contributions to the field of biotechnology, holding a total of eight patents. Her work primarily focuses on the development of innovative methods and products that have the potential to advance medical diagnostics and therapeutics.

Latest Patents

Kajkowski's latest patents include groundbreaking inventions such as heterologous G protein-coupled receptors expressed in yeast. This patent details expression vectors and yeast cells that contain a heterologous G protein-coupled receptor gene, along with gene mutations that enhance sensitivity to receptor activation. Additionally, she has developed methods for producing yeast cells that can be utilized in bioassays. Another notable patent involves β-amyloid peptide-binding proteins and the polynucleotides encoding them. This invention provides novel proteins that bind to human β-amyloid peptide, along with methods for producing these proteins and their applications in diagnostics and therapeutics.

Career Highlights

Throughout her career, Eileen has worked with notable companies such as BASF Aktiengesellschaft and American Cyanamid Company. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in biotechnology.

Collaborations

Eileen has collaborated with esteemed colleagues, including Mark Henry Pausch and Bradley Alton Ozenberger. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Eileen Marie Kajkowski is a distinguished inventor whose work in biotechnology has led to numerous patents and advancements in the field. Her contributions continue to impact medical science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…